Latest News

Establishment of Nyrada Inc.
Positive Clinical Outcomes for NOX66 at ESMO Conference
NOX CEO Interview explains recent Brain Cancer Announcement
Important Brain Cancer Findings for NOX66 Program
Reinstatement to Official Quotation
Noxopharm raises $5.5 million to advance clinical program
Suspension from Official Quotation
Trading Halt Request
Trading Halt
NOX Corporate Presentation ahead of Conference